Navigation Links
Longer treatment benefits sleep apnea patients

WHAT: Adults with obstructive sleep apnea benefit significantly from longer nightly use of continuous positive airway pressure (CPAP), a device to improve breathing during sleep, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. This is the first study to identify the nightly duration of CPAP use needed to gain maximum benefit for daytime alertness and functioning.

Researchers at seven sleep centers in the United States and Canada studied 149 adults with sleep apnea to determine how long they routinely used CPAP each night. In addition, patients were evaluated for daytime symptoms such as excessive daytime sleepiness using two widely accepted assessment tools, and for daytime functioning using a standardized test before treatment and after three months of CPAP therapy. The findings suggest that most patients should use CPAP for at least 7.5 hours each night to realize the greatest possible benefits of therapy.

"Relationship Between Hours of CPAP Use and Achieving Normal Levels of Sleepiness and Daily Functioning," is published in the June issue of the journal SLEEP.

More than 12 million adult Americans are believed to have sleep apnea, a common disorder in which the upper airway is intermittently narrowed during sleep, causing breathing to be difficult or even completely blocked. The CPAP device is worn while the patient sleeps and works by blowing just enough air into the nose to keep the patient's throat open.

Because they often find the CPAP device cumbersome, many patients do not use it consistently or for long enough periods while sleeping. In the current study, for example, patients used CPAP on average about 5 hours a night. The researchers found that although daytime sleepiness could be improved after 4 hours to 6 hours a night, depending on the measurement used, functional status or quality-of-life improvements were maximized after 7.5 hours of use each night. Although individual patient response to CPAP therapy can vary, these latest findings provide a yardstick to help clinicians assess whether a patient's use is optimal.
'"/>

Source:NIH/National Heart, Lung and Blood Institute


Related biology news :

1. Longer-lived rodents have lower levels of thyroid hormone
2. Protein discovery could unlock the secret to better TB treatment
3. Topical treatment shown to inhibit HIV and herpes simplex virus infection
4. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
5. Researchers add new tool to tumor-treatment arsenal
6. Potential treatments for neurofibromatosis
7. Nanoparticles offer new hope for detection and treatment
8. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
9. PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment
10. New understanding of DNA repair may pave way to cancer treatments
11. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
(Date:3/21/2016)... 2016 Unique technology combines ... superior security   Xura, Inc. ... secure digital communications services, today announced it is working ... enterprise customers, particularly those in the Financial Services Sector, ... authentication within a mobile app, alongside, and in combination ...
(Date:3/14/2016)... , March 14, 2016 NXTD ) ... mobile commerce market, announces the airing of a new series ... the week of March 21 st .  The commercials will ... its popular Squawk on the Street show. --> ... the growing mobile commerce market, announces the airing of a ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... 27, 2016 , ... The Board of Directors of Biohaven ... Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, Inc. ... responsible for the commercialization of multiple orphan drug indications. Mr. Tilton has ...
(Date:4/27/2016)... MD (PRWEB) , ... April 27, 2016 , ... ... Greg Lamka, PhD to its Scientific Advisory Board. Dr. Lamka will assist PathSensors ... plant pathogen detection. , PathSensors deploys the CANARY® test platform for the ...
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells Group CEO Benito ... the founder of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received ... cell transplantation for hematologic disorders and the suppression of graft vs. host disease (GVHD) ...
(Date:4/27/2016)... April 27, 2016 MedDay, a biotechnology ... announces the appointment of Catherine Moukheibir as Chairman of its ... Chairman, Jean Jacques Garaud , who contributed to the ... effective immediately. Catherine started her career in strategy ... and London .  She held C-Suite level ...
Breaking Biology Technology: